Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2900 of 3173 entries
View as:

Vyndaqel Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Phase: N/A Priority: Normal
NCT ID: NCT02146378 Org: User:
Start: 01/10/14 End: 03/10/23 Due: 03/10/24

A Study to Evaluate AAV9 Neutralizing Antibody Seroconversion in Household Contacts.

Phase: N/A Priority: Normal
NCT ID: NCT04543357 Org: User:
Start: 08/17/22 End: 02/27/24 Due: 02/27/25

Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT04305587 Org: User:
Start: 03/16/20 End: 07/14/21 Due: 07/14/22

Drug Drug Interaction Study Of Crizotinib With Esomeprazole.

Phase: N/A Priority: Normal
NCT ID: NCT01549574 Org: User:
Start: 05/31/12 End: 05/31/12 Due: 05/31/13

Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics

Phase: N/A Priority: Normal
NCT ID: NCT03964649 Org: User:
Start: 01/01/19 End: 04/06/20 Due: 04/06/21

A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese

Phase: N/A Priority: Normal
NCT ID: NCT06567327 Org: User:
Start: 08/28/24 End: 04/14/25 Due: 04/14/26

A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00643136 Org: User:
Start: 11/30/02 End: 06/30/04 Due: 06/30/05

A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction

Phase: N/A Priority: Normal
NCT ID: NCT00663767 Org: User:
Start: 04/07/08 End: 06/20/08 Due: 06/20/09

A Safety And Efficacy Study of Ibuprofen 250 mg / Acetaminophen 500 mg In The Treatment Of Post-Surgical Dental Pain

Phase: N/A Priority: Normal
NCT ID: NCT02912650 Org: User:
Start: 09/30/15 End: 06/30/16 Due: 06/30/17

Caverject User Study

Phase: N/A Priority: Normal
NCT ID: NCT01008605 Org: User:
Start: 02/28/11 End: 02/28/11 Due: 02/28/12

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Phase: N/A Priority: Normal
NCT ID: NCT01372150 Org: User:
Start: 11/17/11 End: 03/20/15 Due: 03/20/16

Tanezumab in Osteoarthritis of the Hip or Knee (2)

Phase: N/A Priority: Normal
NCT ID: NCT00863304 Org: User:
Start: 06/09/09 End: 08/16/10 Due: 08/16/11

A Study to Evaluate the Efficacy and Safety of Quinapril or Quinapril Plus Hydrochlorothiazide in Patients With Mild to Moderate Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00651287 Org: User:
Start: 12/31/02 End: 06/30/04 Due: 06/30/05

Colombia Epidemiologic Surveillance Study

Phase: N/A Priority: Normal
NCT ID: NCT00428051 Org: User:
Start: 09/30/06 End: 10/31/11 Due: 10/31/12

A Phase I Open-Label Study of the Effects of Tacrolimus and Cyclosporine on CP-690,555 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00860496 Org: User:
Start: 06/30/09 End: 08/31/09 Due: 08/31/10

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT04875533 Org: User:
Start: 06/14/21 End: 05/13/22 Due: 05/13/23

Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT02776644 Org: User:
Start: 10/15/16 End: 12/30/17 Due: 12/30/18

Safety and Tolerability Study of Multiple Doses of PF-06305591

Phase: N/A Priority: Normal
NCT ID: NCT01776619 Org: User:
Start: 04/30/13 End: 11/30/13 Due: 11/30/14

MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT04440163 Org: User:
Start: 06/17/20 End: 07/24/22 Due: 07/24/23

Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00004861 Org: User:
Start: 10/31/99 End: 09/30/01 Due: 09/30/02

Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC

Phase: N/A Priority: Normal
NCT ID: NCT03674827 Org: User:
Start: 11/27/18 End: 09/27/21 Due: 09/27/22

Pre-approval Single-patient Expanded Access for Elranatamab (PF-06863135)

Phase: N/A Priority: Normal
NCT ID: NCT05238311 Org: User:
Start: - End: - Due: -

Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03627767 Org: User:
Start: 06/11/18 End: 10/07/20 Due: 10/07/21

LORA-PITA IV General Investigation

Phase: N/A Priority: Normal
NCT ID: NCT03905798 Org: User:
Start: 11/18/19 End: 11/15/23 Due: 11/15/24

Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients

Phase: N/A Priority: Normal
NCT ID: NCT01227395 Org: User:
Start: 07/31/02 End: 03/31/12 Due: 03/31/13